Literature DB >> 31452243

miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.

Youxia Liao1, Lirong Cao2, Fang Wang3, Rong Pang4.   

Abstract

Lung cancer is an significant cause of death worldwide, and non-small-cell lung cancer (NSCLC) is the most common type of lung cancer. MicroRNAs (miRNAs) have been identified to play key roles in NSCLC development. Recently, it has been reported that miR-605-5p is a cancer-related miRNA in several types of tumors. In this study, we study the role of miR-605-5p in NSCLC cells. We find that miR-605-5p is upregulated in NSCLC cells. Overexpression of miR-605-5p significantly promotes lung cancer invasion and migration in H460 and H1299 cells. Besides this, miR-605-5p also promotes lung cancer cell carcinoma proliferation and metastasis in vivo. However, downregulation of miR-605-5p inhibits cell invasion and migration by inhibiting lung cancer cell carcinoma proliferation and metastasis. In addition, the luciferase report assay identifies 3'-untranslated region tumor necrosis factor α-induced protein 3 (TNFAIP3) as a target of miR-605-5p. Silencing of TNFAIP3 promotes invasion and proliferation in lung cancer. In addition, the knockdown of TNFAIP3 restores the significant decrease in invasion and proliferation in miR-605-5p-inhibitor-transfected lung cancer cells. In conclusion, miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in NSCLC, and may provide possible biomarkers for NSCLC therapy.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  NSCLC; TNFAIP3; cell proliferation; invasion; miR-605-5p

Mesh:

Substances:

Year:  2019        PMID: 31452243     DOI: 10.1002/jcb.29323

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  miR-202-3p negatively regulates MMP-1 to inhibit the proliferation, migration and invasion of lung adenocarcinoma cells.

Authors:  Yong Li; Huiqin Huang; Xiangli Ye; Zhenghui Huang; Xiangqi Chen; Feng Wu; Tingyan Lin
Journal:  Cell Cycle       Date:  2021-01-25       Impact factor: 4.534

2.  MicroRNA-9-5p Facilitates Lung Adenocarcinoma Cell Malignant Progression via Targeting STARD13.

Authors:  Yunping Lu; Weifen Zheng; Xiao Rao; Yinggan Du; Jianbo Xue
Journal:  Biochem Genet       Date:  2022-02-04       Impact factor: 1.890

3.  Exosomal Transfer of lncRNA H19 Promotes Erlotinib Resistance in Non-Small Cell Lung Cancer via miR-615-3p/ATG7 Axis.

Authors:  Rongtao Pan; Haiyan Zhou
Journal:  Cancer Manag Res       Date:  2020-06-08       Impact factor: 3.989

4.  Distinguishable Prognostic miRNA Signatures of Head and Neck Squamous Cell Cancer With or Without HPV Infection.

Authors:  Xiao-Jie Luo; Min Zheng; Ming-Xin Cao; Wei-Long Zhang; Mei-Chang Huang; Li Dai; Ya-Ling Tang; Xin-Hua Liang
Journal:  Front Oncol       Date:  2021-02-10       Impact factor: 6.244

5.  Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.

Authors:  Fuan Wang; Ling Li; Zhen Zhang
Journal:  Mol Med Rep       Date:  2020-11-25       Impact factor: 2.952

6.  miR‑491‑3p functions as a tumor suppressor in non‑small cell lung cancer by targeting fibroblast growth factor 5.

Authors:  Gai Zhang; Haijian Zheng; Ling Wang
Journal:  Oncol Rep       Date:  2022-07-22       Impact factor: 4.136

7.  Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes.

Authors:  Xiaoqiong He; Qian Yao; Dan Fan; Yutong You; Wenjing Lian; Zhangping Zhou; Ling Duan
Journal:  Discov Oncol       Date:  2022-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.